Xenon Pharmaceuticals, Inc. (XENE)
58.65
-0.15
(-0.26%)
USD |
NASDAQ |
Sep 11, 16:00
58.40
-0.25
(-0.43%)
After-Hours: 06:28
Xenon Pharmaceuticals Enterprise Value : 4.750B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.750B |
| September 10, 2026 | 4.765B |
| September 09, 2026 | 4.782B |
| September 08, 2026 | 4.837B |
| September 04, 2026 | 4.857B |
| September 03, 2026 | 4.920B |
| September 02, 2026 | 4.896B |
| September 01, 2026 | 4.881B |
| August 31, 2026 | 4.902B |
| August 28, 2026 | 4.880B |
| August 27, 2026 | 5.068B |
| August 26, 2026 | 5.248B |
| August 25, 2026 | 4.922B |
| August 24, 2026 | 4.935B |
| August 21, 2026 | 4.955B |
| August 20, 2026 | 4.855B |
| August 19, 2026 | 5.105B |
| August 18, 2026 | 5.189B |
| August 17, 2026 | 5.109B |
| August 14, 2026 | 5.108B |
| August 13, 2026 | 5.290B |
| August 12, 2026 | 5.390B |
| August 11, 2026 | 5.192B |
| August 10, 2026 | 5.290B |
| August 07, 2026 | 5.206B |
| Date | Value |
|---|---|
| August 06, 2026 | 5.321B |
| August 05, 2026 | 5.297B |
| August 04, 2026 | 5.269B |
| August 03, 2026 | 5.100B |
| July 31, 2026 | 5.139B |
| July 30, 2026 | 5.286B |
| July 29, 2026 | 5.181B |
| July 28, 2026 | 5.359B |
| July 27, 2026 | 5.440B |
| July 24, 2026 | 5.405B |
| July 23, 2026 | 5.405B |
| July 22, 2026 | 5.479B |
| July 21, 2026 | 5.533B |
| July 20, 2026 | 5.465B |
| July 17, 2026 | 5.680B |
| July 16, 2026 | 5.556B |
| July 15, 2026 | 5.627B |
| July 14, 2026 | 5.587B |
| July 13, 2026 | 5.628B |
| July 10, 2026 | 5.744B |
| July 09, 2026 | 5.941B |
| July 08, 2026 | 5.844B |
| July 07, 2026 | 5.207B |
| July 06, 2026 | 4.933B |
| July 02, 2026 | 4.974B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Psyence Biomedical Ltd. | -- |
| Aurinia Pharmaceuticals, Inc. | 1.761B |
| enGene Therapeutics, Inc. | -112.50M |
| Medicus Pharma Ltd. | 14.37M |
| ACADIA Pharmaceuticals, Inc. | 3.908B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -110.74M |
| Total Expenses (Quarterly) | 110.74M |
| EPS Diluted (Quarterly) | -1.112 |
| Earnings Yield | -8.09% |
| Normalized Earnings Yield | -8.088 |